Osnate-D Tablet: Uses, Dosage & Side Effects in Pakistan

Osnate-D Tablet Uses, Dosage, Side Effects & Price in Pakistan

1. Quick Info (Mukhtasir Maloomat)

2. What is Osnate-D Tablet? (Osnate-D Tablet kya hai)

Osnate-D combines ossein mineral complex with vitamin D3. The AGP product information describes calcium, phosphorus and bone-matrix components in the ossein complex. Vitamin D3 is converted in the body to active vitamin D. These ingredient facts do not establish that this formulation is superior to every other calcium supplement.

3. Uses (Fayde / Kis kaam aati hai)

• Osteoporosis prevention and treatment (bone density support)
• Calcium and Vitamin D3 deficiency supplementation
• Post-menopausal bone loss prevention
• Steroid-induced osteoporosis prevention
• Adjunct to bisphosphonate therapy for osteoporosis
• Calcium supplementation in pregnancy and lactation (under doctor guidance)

4. Who May Use It (Kis ko leni chahiye)

A healthcare professional should confirm that the indication, age and exact formulation match the patient’s needs. An ingredient match alone does not make another brand or formulation interchangeable.

5. When Not to Use (Kab nahi leni chahiye)

• Avoid excess calcium or vitamin D; discuss high calcium, kidney stones and severe kidney disease with the prescriber.
• Minerals can reduce absorption of some antibiotics, thyroid medicine and bisphosphonates. The separation interval is medicine-specific; ask a pharmacist.
• Thiazide diuretics can increase the risk of raised calcium.

6. Dosage (Kitni leni hai)

Adult guidance

AGP lists 1–2 tablets daily before meals with liquid. Osteoporosis dosing is individualised by the physician.

Child guidance

Not indicated as a primary supplement for children. Consult a paediatrician for paediatric bone health supplementation.

Dose limits

Use the limit specified for your exact product and individual prescription. A strength printed on a pack is not automatically a recommended dose.

7. How to Use (Kaise leni hai)

Check the medicine name, strength and instructions before each course. Do not share a prescription or change its dose, duration or formulation without professional advice.

8. Timing (Kab leni chahiye)

AGP’s instructions say before meals with some liquid.

9. Missed Dose (Dose chhoot jaye)

Follow the exact leaflet or contact a pharmacist for missed-dose instructions. Do not double a dose or change a tapering or monitored treatment plan yourself.

10. Warnings (Ihtiyat)

• Avoid excess calcium or vitamin D; discuss high calcium, kidney stones and severe kidney disease with the prescriber.
• Minerals can reduce absorption of some antibiotics, thyroid medicine and bisphosphonates. The separation interval is medicine-specific; ask a pharmacist.
• Thiazide diuretics can increase the risk of raised calcium.

11. Precautions (Ahm ehtiyaat)

Check allergies, pregnancy or breastfeeding, kidney and liver conditions, and all other medicines with the prescriber or pharmacist. Store according to the local pack and keep out of reach of children. Below 30°C. Keep in original packaging. Keep away from moisture and direct sunlight.

12. Side Effects (Nuksanat)

Reported effects

• Constipation — most common calcium supplement side effect
• Nausea and mild stomach discomfort
• Bloating and gas

Serious effects and warning symptoms

• Hypercalcaemia (excess blood calcium) — nausea, weakness, confusion, kidney stones (if dose is excessive)
• Nephrolithiasis (kidney stones) — in predisposed patients with high calcium intake
• Vitamin D toxicity — very unlikely at 400 IU per tablet

These lists do not establish the frequency of an effect or prove that a new symptom is caused by this medicine. Persistent or worsening symptoms need assessment.

13. Interactions (Dawaon ke sath reaction)

Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin); Tetracyclines; Bisphosphonates (alendronate); Iron supplements; Zinc; Thiazide diuretics; Corticosteroids (reduce absorption)

14. When to Get Help (Kab doctor se milein)

Seek emergency help for difficulty breathing, swelling of the face or throat, collapse, severe bleeding or suspected overdose. For the medicine-specific warning symptoms above, contact a clinician promptly. Bring the pack and a list of medicines.

15. Alternatives (Dusri dawaein)

Ask a pharmacist to compare the exact ingredients, strength, route and release type. A generic name alone does not prove dose equivalence. Do not substitute a combination product for a single-ingredient treatment.

16. Price in Pakistan (Price kitni hai)

A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

17. FAQs (Aksar poochay jane walay sawalat)

Q: Osnate-D Tablet kis kaam aati hai?

A: Osnate-D Tablet contains Ossein Mineral Complex 830mg + Cholecalciferol (Vitamin D3) 400 IU. Osteoporosis prevention and treatment (bone density support); Calcium and Vitamin D3 deficiency supplementation. The diagnosis and exact product determine suitability.

Q: Dose kaise confirm karein?

A: AGP lists 1–2 tablets daily before meals with liquid. Osteoporosis dosing is individualised by the physician.

Q: Bachon ke liye dose kya hai?

A: Not indicated as a primary supplement for children. Consult a paediatrician for paediatric bone health supplementation.

Q: Pakistan mein price kitni hai?

A: A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

Q: Nuksanat hon to kya karein?

A: Reported effects include Constipation — most common calcium supplement side effect; Nausea and mild stomach discomfort; Bloating and gas. Seek medical help for Hypercalcaemia (excess blood calcium) — nausea, weakness, confusion, kidney stones (if dose is excessive); Nephrolithiasis (kidney stones) — in predisposed patients with high calcium intake. A symptom list does not predict how often an effect occurs.

18. Editorial Information (Medical jaiza)

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-10-15

This correction adds ingredient-specific sources and separates verified facts from unverified local pack details. The recorded medical-review date is unchanged; this editorial correction is not a new clinician review. Foreign labels inform ingredient safety and do not establish Pakistani registration or every local pack’s instructions.

19. Disclaimer (Zaroori tanbeeh)

Educational information only. Confirm the diagnosis, local leaflet and individual prescription with a qualified clinician or pharmacist before starting, stopping or changing treatment.